Profarma Distribuidora Financials
| PFRM3 Stock | BRL 6.84 0.09 1.33% |
Profarma |
Understanding current and past Profarma Distribuidora Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Profarma Distribuidora's financial statements are interrelated, with each one affecting the others. For example, an increase in Profarma Distribuidora's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Profarma Distribuidora's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Profarma Distribuidora de. Check Profarma Distribuidora's Beneish M Score to see the likelihood of Profarma Distribuidora's management manipulating its earnings.
Profarma Distribuidora Stock Summary
Profarma Distribuidora competes with Engie Brasil, WEG SA, Ambev SA, and M Dias. Profarma Distrib Prod Farmaceuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil. PROFARMA operates under Medical Distribution classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 6327 people.| Instrument | Brazil Stock View All |
| Exchange | Sao Paulo Exchange |
| ISIN | BRPFRMACNOR1 |
| Business Address | Avenida Ayrton Senna |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.profarma.com.br |
| Phone | 55 21 4009 0200 |
| Currency | BRL - Brazilian Real |
You should never invest in Profarma Distribuidora without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Profarma Stock, because this is throwing your money away. Analyzing the key information contained in Profarma Distribuidora's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Profarma Distribuidora Key Financial Ratios
There are many critical financial ratios that Profarma Distribuidora's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Profarma Distribuidora reports annually and quarterly.| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0368 | |||
| Target Price | 7.5 | |||
| Beta | 1.14 | |||
| Z Score | 1.0 |
Profarma Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Profarma Distribuidora's current stock value. Our valuation model uses many indicators to compare Profarma Distribuidora value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Profarma Distribuidora competition to find correlations between indicators driving Profarma Distribuidora's intrinsic value. More Info.Profarma Distribuidora de is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Profarma Distribuidora de is roughly 1.75 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Profarma Distribuidora's earnings, one of the primary drivers of an investment's value.Profarma Distribuidora Systematic Risk
Profarma Distribuidora's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Profarma Distribuidora volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Profarma Distribuidora correlated with the market. If Beta is less than 0 Profarma Distribuidora generally moves in the opposite direction as compared to the market. If Profarma Distribuidora Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Profarma Distribuidora is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Profarma Distribuidora is generally in the same direction as the market. If Beta > 1 Profarma Distribuidora moves generally in the same direction as, but more than the movement of the benchmark.
Profarma Distribuidora November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Profarma Distribuidora help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Profarma Distribuidora de. We use our internally-developed statistical techniques to arrive at the intrinsic value of Profarma Distribuidora de based on widely used predictive technical indicators. In general, we focus on analyzing Profarma Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Profarma Distribuidora's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.37 | |||
| Information Ratio | 0.0116 | |||
| Maximum Drawdown | 12.48 | |||
| Value At Risk | (3.66) | |||
| Potential Upside | 4.99 |
Additional Tools for Profarma Stock Analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.